FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on Idenix and Orexigen

Continue Reading

Number of FDA Drug Approvals Reach a 15-Year High in 2012

Research Driven Investing Provides Stocks Research on Cleveland BioLabs and Hyperion Therapeutics

Continue Reading

JDS Uniphase and Pitney Bowes Rise on Fourth Quarter Earnings — S&P 500 Index Hovers Near 5-Year Highs

Research Driven Investing Provides Stocks Research on JDS Uniphase and Pitney Bowes

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Research Driven Investing Provides Stocks Research on Achillion and Galena

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

Research Driven Investing Provides Stocks Research on Cell Therapeutics and Dendreon

Continue Reading

Strong Sales of Marlboro Cigarettes Boosts Altria-s Fourth Quarter Earnings

Research Driven Investing Provides Stocks Research on Altria Group and Philip Morris

Continue Reading

Global Digital Advertising Spending Topped $100 Billion in 2012 — Expected to Grow 15.1% in 2013

Research Driven Investing Provides Stocks Research on AOL and Yahoo!

Continue Reading

U.S. Refining Industry Improve Margins With Domestic Oil

Research Driven Investing Provides Stocks Research on HollyFrontier and Western Refining

Continue Reading

U.S. Refiners Soar in 2012 as Increased Access to North American Crude Improves Margins

Research Driven Investing Provides Stocks Research on Valero Energy and Tesoro

Continue Reading

Six Canadian Banks Ratings Downgraded — Canadian Consumer Debt at a Record High

Research Driven Investing Provides Stocks Research on Bank of Nova Scotia and Royal Bank of Canada

Continue Reading